With the immense regional talent and the prosperous funding environment, more biotech companies from across the country and even around the world are looking to relocate. Cambridge represents the hub of biotech, but is Kendell Square overcrowded and are companies seeking to other possible locations like Harvard Square and across the river into Boston? Will mergers and acquisitions of biotech companies help or hurt the industry? This session will focus on the how the biotech boom will directly affect CRE trends and what to expect for future deals. 

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.